A cross-sectional and diurnal study of thrombogenesis among patients with chronic atrial fibrillation.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of the American College of Cardiology

• Publication date

  2000-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0735-1097(00)00627-6PMID 10841245
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Progressive vascular damage in hypertension is associated with increased levels of circulating P‐selectin

  1998cited by this paper
• Patients with non-valvular atrial fibrillation have evidence of thrombin generation but not endothelial activation

  1998cited by this paper
• Platelet activation in embolic and preembolic status of patients with nonrheumatic atrial fibrillation.

  1997cited by this paper
• Circadian variation of paroxysmal atrial fibrillation.

  1997cited by this paper
• Atrial fibrillation activates platelets and coagulation in a time-dependent manner: a study in patients with paroxysmal atrial fibrillation.

  1997cited by this paper
• Hypothesis: is soluble P-selectin a new marker of platelet activation?

  1997cited by this paper
• The Origin of P-selectin as a Circulating Plasma Protein

  1997cited by this paper
• Fibrin D-dimer and beta-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirin.

  1996cited by this paper
• Large-scale screening for factor V Leiden mutation in a north-eastern German population.

  1996cited by this paper
• Soluble P-selectin as Parameter for Platelet Activation during Storage

  1996cited by this paper
• Plasma levels of thrombomodulin in pulmonary hypertension.

  1996cited by this paper
• Increased levels of plasma thrombomodulin are associated with vascular and all-cause mortality in patients on long-term anticoagulant treatment.

  1996cited by this paper
• Considering cellular thrombomodulin distribution and its modulating factors can facilitate the use of plasma thrombomodulin as a reliable endothelial marker?

  1996cited by this paper
• Does atrial fibrillation confer a hypercoagulable state?

  1995cited by this paper
• Does atrial fibrillation confer a hypercoagulable state

  1995cited by this paper
• von Willebrand Factor, Soluble P-Selectin, Tissue Plasminogen Activator and Plasminogen Activator Inhibitor in Atherosclerosis

  1995cited by this paper
• Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment.

  1995cited by this paper
• Platelet activation is not involved in acceleration of the coagulation system in acute cardioembolic stroke with nonvalvular atrial fibrillation.

  1995cited by this paper
• Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials.

  1994cited by this paper
• Plasma P-selectin is increased in thrombotic consumptive platelet disorders.

  1994cited by this paper
• Plasma P-selectin is increased in thrombotic consumptive platelet disorders

  1994cited by this paper
• Circadian Variation of Sudden Cardiac Death Reflects Age‐Related Variability in Ventricular Fibrillation

  1993cited by this paper
• Levels of plasma thrombomodulin are increased in atheromatous arterial disease.

  1993cited by this paper
• Circadian variation in platelet function in healthy volunteers.

  1992cited by this paper
• Prothrombin fragment F1 + 2 and thrombin-antithrombin III complex are useful markers of the hypercoagulable state in atrial fibrillation.

  1992cited by this paper
• Increased onset of sudden cardiac death in the first three hours after awakening.

  1992cited by this paper
• Prospective evidence of a circadian rhythm for out-of-hospital cardiac arrests.

  1992cited by this paper
• Circadian variation of endothelial cell function, red blood cell deformability and dehydro‐thromboxane B2 in healthy volunteers

  1991cited by this paper
• Soluble Thrombomodulin Antigen in Conditioned Medium Is Increased by Damage of Endothelial Cells

  1991cited by this paper
• Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.

  1991cited by this paper
• Up-regulation of thrombomodulin in human umbilical vein endothelial cells in vitro.

  1990cited by this paper
• Increased intracardiovascular clotting in patients with chronic atrial fibrillation.

  1990cited by this paper
• Variation of Occurrence

  1989cited by this paper
• Thrombomodulin.

  1989cited by this paper
• Circadian variation of total ischaemic burden and its alteration with anti-anginal agents.

  1988cited by this paper
• Circadian variation in the frequency of sudden cardiac death.

  1987cited by this paper
• Circadian variation of transient myocardial ischemia in patients with coronary artery disease.

  1987cited by this paper
• Circadian changes in anticoagulant effect of heparin infused at a constant rate.

  1985cited by this paper
• Diurnal variation of and activity during the onset of stroke.

  1985cited by this paper
• Circadian variation in the frequency of onset of acute myocardial infarction.

  1985cited by this paper
• Diurnal Variation in Occurrence of Strokes

  1977cited by this paper
• The Framingham study.

  1976cited by this paper

• The association of coagulation and atrial fibrillation: a systematic review and meta-analysis

  2022cites this paper
• Soluble Platelet Release Factors as Biomarkers for Cardiovascular Disease

  2021cites this paper
• Endothelial function in patients with atrial fibrillation

  2020cites this paper
• Prospective associations of sleep apnea, periodic limb movements, and plasma fibrinogen level

  2020cites this paper
• Biomarkers in patients with Takotsubo cardiomyopathy compared to patients with acute anterior ST-elevation myocardial infarction

  2020cites this paper
• Endocardial Changes in Nonvalvular Atrial Fibrillation Without Atrial Thrombus—Thrombomodulin and Tissue Factor Pathway Inhibitor

  2018cites this paper
• The Multiple Causes of Stroke in Atrial Fibrillation: Thinking Broadly.

  2018cites this paper
• Von Willebrand factor and ADAMTS13 plasma in older patients with high CHA2DS2-VASc Score with and without atrial fibrillation.

  2017cites this paper
• Predictive Role of Coagulation, Fibrinolytic, and Endothelial Markers in Patients with Atrial Fibrillation, Stroke, and Thromboembolism: A Meta-Analysis, Meta-Regression, and Systematic Review

  2017cites this paper
• Platelets Cellular and Functional Characteristics in Patients with Atrial Fibrillation: A Comprehensive Meta-Analysis and Systematic Review

  2017cites this paper
• Update on ADAMTS13 and VWF in cardiovascular and hematological disorders.

  2016cites this paper
• LETTERS TO THE EDITOR Coronary Endothelial Dysfunction in the Early Months After Heart Transplantation

  2016cites this paper
• Effects of Aging on the Coagulation Fibrinolytic System in Outpatients of the Cardiovascular Department.

  2016cites this paper
• Evaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic Substrate

  2015cites this paper
• Inflammatory Biomarkers and Atrial Fibrillation: Potential Role of Inflammatory Pathways in the Pathogenesis of Atrial Fibrillation-induced Thromboembolism.

  2015cites this paper
• Association of Hemostatic Markers with Atrial Fibrillation: A Meta-Analysis and Meta-Regression

  2015cites this paper
• Influencia del remodelado intersticial en la caída en fibrilación auricular en pacientes sometidos a cirugía de revascularización coronaria o recambio valvular aórtico por estenosis aórtica

  2015cites this paper
• Plasma CX3CL1 Levels and Long Term Outcomes of Patients with Atrial Fibrillation: The West Birmingham Atrial Fibrillation Project

  2014cites this paper
• Endothelial (dys)function in lone atrial fibrillation.

  2014cites this paper
• Biomarkers in lone atrial fibrillation - an additional 'fine tuning' of risk?

  2014cites this paper
• Circadian Rhythm in Stroke - The Influence of Our Internal Cellular Clock on Cerebrovascular Events

  2014cites this paper
• Von Willebrand Factor Plasma Levels Variability In Nonvalvular Atrial Fibrillation.

  2014influential citation
• Caracterización biológica y clínica del riesgo trombótico y hemorrágico de pacientes con fibrilación auricular no valvular bajo tratamiento anticoagulante oral.

  2013cites this paper
• Biomarkers in Cardiorenal Syndrome

  2013cites this paper
• The Thrombogenic Role of Platelets in Valvular Atrial Fibrillation

  2012cites this paper
• Biochemical predictors of cardiac rhythm at 1 year follow-up in patients with non-valvular atrial fibrillation

  2012cites this paper
• New peptide pENW (pGlu-Asn-Trp) inhibits platelet activation by attenuating Akt phosphorylation.

  2012cites this paper
• Mechanisms of thrombogenesis in atrial fibrillation.

  2012cites this paper
• Increased Plasma Soluble Thrombomodulin Levels in Cardioembolic Stroke

  2012cites this paper
• Der Einfluss von nicht valvulär bedingtem Vorhofflimmern auf den Stromal cell-derived factor-1 (SDF-1) im Plasma und auf zirkulierenden Thrombozyten bei Patienten mit ischämischer Herzerkrankung

  2012cites this paper
• Atrial fibrillation, arrhythmia burden and thrombogenesis.

  2012cites this paper
• An Update on the Prognosis of Patients With Atrial Fibrillation

  2012cites this paper
• Intracardiac expression of markers of endothelial damage/dysfunction, inflammation, thrombosis, and tissue remodeling, and the development of postoperative atrial fibrillation

  2011cites this paper
• [The Rotterdam study].

  2011cites this paper
• A study of blood soluble P-selectin, fibrinogen, and von Willebrand factor levels in idiopathic and lone atrial fibrillation.

  2011cites this paper
• Relationship of circulating endothelial progenitor cells to the recurrence of atrial fibrillation after successful conversion and maintenance of sinus rhythm.

  2010cites this paper
• Should all patients with non-valvular atrial fibrillation be anticoagulated?

  2010cites this paper
• Persistent atrial fibrillation is not associated with thrombomodulin level increase in efficiently anticoagulated patients

  2010cites this paper
• Temporal changes in circulating P-selectin, plasminogen activator inhibitor-1, magnesium, and creatine kinase after percutaneous coronary intervention

  2010cites this paper
• Changes in plasma von Willebrand factor and ADAMTS13 levels associated with left atrial remodeling in atrial fibrillation.

  2009cites this paper
• Epidemiology of atrial fibrillation in the general population

  2009cites this paper
• Short-term Acute Hyperinsulinemia and Prothrombotic Factors in Subjects with Normal Glucose Tolerance

  2009cites this paper
• Circadian changes in the hemostatic system in healthy men and patients with cardiovascular diseases.

  2009cites this paper
• High-dose erythropoietin alters platelet reactivity and bleeding time in rodents in contrast to the neuroprotective variant carbamyl-erythropoietin (CEPO)

  2008cites this paper
• The endothelium and atrial fibrillation

  2008cites this paper
• Influence of atrial fibrillation on plasma von willebrand factor, soluble E-selectin, and N-terminal pro B-type natriuretic peptide levels in systolic heart failure.

  2008cites this paper
• Thrombomodulin and GFC levels in Legg–Calve–Perthes disease

  2008cites this paper
• Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels.

  2008cites this paper
• Portraits moléculaires des pathologies cardiaques

  2007cites this paper
• Diurnal, Seasonal, and Blood-Processing Patterns in Levels of Circulating Fibrinogen, Fibrin D-Dimer, C-Reactive Protein, Tissue Plasminogen Activator, and von Willebrand Factor in a 45-Year-Old Population

  2007cites this paper
• The Feasibility of Tissue Doppler Acceleration as a New Predictor of Thrombogenesis in the Left Atrial Appendage Associated with Nonvalvular Atrial Fibrillation

  2007cites this paper
• Chronobiology of hemostasis and inferences for the chronotherapy of coagulation disorders and thrombosis prevention.

  2007cites this paper
• Levels of circulating procoagulant microparticles in nonvalvular atrial fibrillation.

  2007cites this paper
• Self-limited bursts of atrial fibrillation following successful cardioversion.

  2007cites this paper
• Thoracic aortic plaque enhances hypercoagulability in patients with nonrheumatic atrial fibrillation.

  2007cites this paper
• Angiotensin II Type 1 Receptor Blocker Prevents Atrial Structural Remodeling in Rats with Hypertension Induced by Chronic Nitric Oxide Inhibition

  2006cites this paper
• The effects of direct current cardioversion for persistent atrial fibrillation on indices of endothelial damage/dysfunction.

  2006cites this paper
• Increased von Willebrand factor in acute stroke patients with atrial fibrillation.

  2006cites this paper
• Atrial fibrillation : Clinical presentation and prevention of recurrences

  2006cites this paper
• Fluctuations in coagulation activity among patients with atrial fibrillation who are stably anticoagulated.

  2006cites this paper
• Gene expression profile associated with chronic atrial fibrillation and underlying valvular heart disease in man.

  2006cites this paper
• Effects of congestive heart failure on plasma von Willebrand factor and soluble P-selectin concentrations in patients with non-valvar atrial fibrillation

  2005cites this paper
• Circulating endothelial cells in atrial fibrillation with and without acute cardiovascular disease

  2005cites this paper
• Dementia in subjects with atrial fibrillation: hemostatic function and the role of anticoagulation

  2004cites this paper
• Haemostatic function and cerebrovascular disease

  2004cites this paper
• Tissue factor expression in atrial endothelia associated with nonvalvular atrial fibrillation: possible involvement in intracardiac thrombogenesis.

  2003cites this paper
• Effects of the Oral Direct Thrombin Inhibitor Ximelagatran on P-Selectin Expression and Thrombin Generation in Atrial Fibrillation

  2003cites this paper
• Thrombomodulin and Tissue Factor Pathway Inhibitor in Endocardium of Rapidly Paced Rat Atria

  2003cites this paper
• Atrial Fibrillation and the Hypercoagulable State: From Basic Science to Clinical Practice

  2003cites this paper
• Hyperhomocysteinemia Is Associated With the Presence of Left Atrial Thrombus in Stroke Patients With Nonvalvular Atrial Fibrillation

  2003cites this paper
• Atrial Fibrillation and the Prothrombotic State in the Elderly: The Rotterdam Study

  2003cites this paper
• Fibrinolytic function and atrial fibrillation.

  2003cites this paper
• Prognostic Value of Plasma von Willebrand Factor and Soluble P-Selectin as Indices of Endothelial Damage and Platelet Activation in 994 Patients With Nonvalvular Atrial Fibrillation

  2003cites this paper
• Diurnal and Seasonal Variation of Stroke Incidence in Patients with Cardioembolic Stroke due to Atrial Fibrillation

  2003cites this paper
• Interleukin-6, tissue factor and von Willebrand factor in acute decompensated heart failure: relationship to treatment and prognosis

  2003cites this paper
• Aspirin inhibits surface glycoprotein IIb/IIIa, P‐selectin, CD63, and CD107a receptor expression on human platelets

  2003cites this paper
• Review Article Fibrinolytic function and atrial fibrillation

  2003cites this paper
• Plasma von Willebrand Factor and Soluble P-Selectin as Indices of Endothelial Damage and Platelet Activation in 1321 Patients With Nonvalvular Atrial Fibrillation: Relationship to Stroke Risk Factors

  2002cites this paper
• Reimbursement Claims Analysis of Outcomes with Carvedilol and Metoprolol

  2002cites this paper
• Aortic spontaneous echocardiographic contrast and hemostatic markers in patients with nonrheumatic atrial fibrillation.

  2002cites this paper
• Cholesterol and carotid stenosis.

  2002cites this paper
• A prospective randomized trial of aspirin-clopidogrel combination therapy and dose-adjusted warfarin on indices of thrombogenesis and platelet activation in atrial fibrillation.

  2002cites this paper
• Do cardiac glycosides affect platelet function? A flow cytometric study in healthy volunteers.

  2002cites this paper
• Diurnal variation in the intensity of anticoagulation in atrial fibrillation.

  2002cites this paper
• Diurnal variation of international normalised ratio in patients under oral anticoagulation.

  2002cites this paper
• A study of platelet activation in atrial fibrillation and the effects of antithrombotic therapy.

  2002cites this paper
• Diurnal Variation in Stroke Onset in Atrial Fibrillation

  2001cites this paper
• Mario Di Napoli Systemic Complement Activation in Ischemic Stroke

  2001cites this paper
• Increased von Willebrand factor in the endocardium as a local predisposing factor for thrombogenesis in overloaded human atrial appendage.

  2001cites this paper
• : Cost and Outcome of Mechanical Ventilation for Life-Threatening Stroke

  2001cites this paper
• Increased von Willebrand factor in the endocardium as a local predisposing factor for thrombogenesis in overloaded human atrial appendage.

  2001cites this paper
• Diurnal variation in stroke onset in atrial fibrillation.

  2001cites this paper
• Platelets and atrial fibrillation.

  2001cites this paper
• Diurnal rhythms and hemostatic factors in atrial fibrillation.

  2001cites this paper
• Diurnal variation and cardiovascular disease.

  2001cites this paper
• Cholesterol and Carotid Stenosis

  2001cites this paper
• Diurnal rhythms and hemostatic factors in atrial fibrillation: reply

  2001cites this paper
• Uniform platelet activation exists before coronary stent implantation despite aspirin therapy.

  2001cites this paper
• Beta-blockers in syncope: the jury is still out.

  2001cites this paper
• Diurnal Variation in Stroke Onset in Atrial Fibrillation

  2001cites this paper